Welcome, friends!

If you’re obsessed with health-tech, this is the newsletter for you!

I’ll draw on a decade of experience covering the industry as a reporter at CNBC, Fast Company and Reuters - and now as an investor at OMERS Ventures - to share my unfiltered thoughts with you. During my tenure as a reporter, I broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. I also appeared on air (that’s me, below right) to chat about the biggest digital health news of the moment.

In my new role as an investor, I’ll be researching a variety of trends including women’s health, behavioural health and pharmacy tech. And I’ll share what I learn along the way. You’ll also meet my occasional co-author Michael Yang, Managing Partner at OMERS Ventures and a health-tech investor to his core.

Why subscribe?

Second Opinion will feature analysis and interviews with founders, executives, investors and operators on the future of health care. The goal is to leverage my network to get into the context (in journalism, we call it the “so what”) behind the news of the moment. My solemn promise is to do this without bombarding your inbox.

Join the crew

I want to hear from you. If there’s a topic I should be writing about, reach out on Twitter at @chrissyfarr.

Subscribe to Second Opinion

Our bi-monthly deep dive into the latest health-tech news and trends.


Christina Farr
Health + tech.
Harry Briggs
Founder turned VC at OMERSventures (previously Balderton Capital). Early investor in Revolut, Paddle, Touch Surgery, GoCardless, Gousto etc. Pianist. Psychologist. Optimist.